Luye Pharma Group Ltd. (LYPHF)

PNK: LYPHF · Real-Time Price · USD

0.27

0.01 (5.80%)

At close: Apr 29, 2025, 9:30 AM

Luye Pharma Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	3.34B	5.65B	4.47B	2.32B	3.37B	2.44B	4.94B	3.87B	3.78B	2.33B	1.27B	1.67B	1.8B	1.27B	1.43B	397.77M	3.16B
Short-Term Investments	1.51B	2.87B	3.43B	3.22B	2.19B	3.07B	1.4B	1.54B	1.58B	2.86B	3.94B	3.19B	2.69B	2.58B	1.49B	2.35B	761.35M
Long-Term Investments	1.57B	1.97B	-2.84B	-2.11B	-1.61B	-2.49B	-1.29B	-1.47B	-1.5B	-2.79B	-3.86B	-3.11B	-2.61B	-2.53B	-1.48B	-2.34B	-751.99M
Other Long-Term Assets	302.09M	187.44M	3.59B	3.56B	2.43B	3.52B	1.61B	1.85B	1.73B	2.91B	3.94B	3.19B	2.69B	2.58B	1.49B	2.35B	761.35M
Receivables	3.51B	2.35B	2.19B	1.78B	1.93B	1.77B	1.77B	1.55B	1.85B	1.81B	1.76B	1.53B	1.43B	1.41B	1.37B	1.42B	1.51B
Inventory	815.55M	827.86M	803.61M	772.94M	784.63M	746.34M	626.74M	612.3M	631.77M	614.62M	636.11M	585.61M	529.25M	420.36M	440.33M	452.67M	330.2M
Other Current Assets	1.56B	1.32B	2.21B	2.22B	2.01B	2.37B	2.37B	2.31B	1.99B	3.16B	3.13B	3.03B	2.66B	1.69B	2.52B	1.21B	2B
Total Current Assets	12.54B	10.7B	13.11B	10.79B	10.27B	10.4B	10.9B	9.97B	9.18B	9.36B	9.33B	8.68B	7.85B	6.3B	6.67B	5.28B	7.15B
Property-Plant & Equipment	5.26B	5.13B	5.03B	4.91B	4.72B	4.59B	4.53B	4.34B	4.23B	4.21B	3.6B	3.2B	2.78B	2.46B	2.16B	1.97B	1.54B
Goodwill & Intangibles	7.53B	7.36B	7.25B	6.99B	6.64B	6.43B	5.97B	5.83B	5.81B	5.52B	5.47B	5.49B	5.37B	1.87B	1.89B	1.85B	466.68M
Total Long-Term Assets	14.66B	14.79B	13.19B	13.46B	12.3B	12.19B	10.95B	10.66B	10.39B	9.95B	9.26B	8.86B	8.3B	4.46B	4.15B	3.92B	2.11B
Total Assets	27.2B	25.49B	26.3B	24.25B	22.57B	22.58B	21.84B	20.63B	19.56B	19.31B	18.6B	17.54B	16.16B	10.76B	10.83B	9.21B	9.26B
Account Payables	797.01M	767.19M	665.15M	559.94M	442.6M	570.89M	722.62M	485.26M	467.46M	341.05M	568.18M	279.75M	132.82M	104.6M	110.97M	116.14M	93.61M
Deferred Revenue	n/a	-18.5M	n/a	n/a	n/a	n/a	238.55M	358.09M	1.4B	1.29B	2.81B	2.59B	654.69M	631.24M	647.52M	629.5M	461.25M
Short-Term Debt	6.65B	5.18B	7.75B	6.82B	5.4B	5.24B	4.65B	5.63B	4.39B	4.02B	4.16B	5.29B	5.94B	2.86B	3.19B	1.62B	2.24B
Other Current Liabilities	29.42M	1.43B	2.23B	1.4B	1.55B	1.07B	708.78M	537.42M	12.05M	819.29M	19.7M	-336.67M	52.71M	-192.41M	699.89M	-191.28M	528.78M
Total Current Liabilities	9.77B	8.14B	11.41B	9.49B	7.4B	7.33B	6.34B	7.23B	6.31B	5.55B	7.56B	8.2B	6.79B	3.65B	4B	2.37B	2.86B
Long-Term Debt	2.73B	3.18B	2.08B	2.24B	3.76B	4.21B	4.24B	4.33B	4.57B	4.5B	1.91B	847.51M	5.28M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	555.08M	596.22M	590.68M	1.46B	1.94B	1.91B	1.57B	958.81M	626.46M	-114.68M	317.63M	554.25M	1.84B	209.46M	n/a	n/a	n/a
Total Long-Term Liabilities	3.34B	3.82B	2.7B	3.72B	5.72B	6.14B	5.81B	5.3B	5.43B	4.4B	2.51B	1.4B	2.04B	209.69M	259.36M	269.07M	173.85M
Total Liabilities	13.11B	11.96B	14.11B	13.21B	13.12B	13.47B	12.15B	12.53B	11.74B	9.94B	10.07B	9.6B	8.83B	3.86B	4.26B	2.64B	3.04B
Total Debt	9.45B	8.42B	9.87B	9.1B	9.19B	9.49B	8.91B	9.98B	8.99B	8.07B	6.07B	6.14B	5.94B	2.86B	3.19B	1.62B	2.24B
Common Stock	486.11M	486.11M	486.11M	456.95M	456.95M	455.83M	455.83M	417.99M	417.99M	420.56M	421.34M	421.34M	421.34M	427.27M	427.27M	427.27M	427.27M
Retained Earnings	6.45B	7.38B	7B	6.67B	6.35B	6.06B	6.59B	6.21B	5.99B	5.69B	5.42B	4.84B	4.23B	3.81B	2.94B	2.67B	2.36B
Comprehensive Income	n/a	7.89B	155M	254.46M	502.31M	534.04M	559.22M	501.52M	420.1M	-1.08B	100.82M	-888.71M	58.95M	-735.07M	-240.9M	-592.79M	44.13M
Shareholders Equity	13.02B	12.53B	11.33B	10.18B	8.81B	8.49B	9.14B	7.89B	7.67B	9.22B	8.39B	7.81B	7.2B	6.77B	6.44B	6.43B	6.09B
Total Investments	3.08B	1.97B	598.58M	1.11B	581.2M	582.2M	108.78M	71.46M	80.14M	71.87M	78.56M	83.57M	75.54M	40.81M	8.99M	8.49M	9.36M